On Tuesday after Congress returned from recess, Rep. Dana Rohrbacher published a column in the Washington Post asking his conservative colleagues to support his budget amendment that would protect state-legal medical marijuana patients and providers from federal interference.
Not long ago, a supporter of mine, visiting from California, dropped by my Capitol office. A retired military officer and staunch conservative, he and I spent much of our conversation discussing the Republican agenda.
Finally, I drew a breath and asked him about an issue I feared might divide us: the liberalization of our marijuana laws, specifically medical marijuana reform, on which for years I had been leading the charge. What did he think about that controversial position?
“Dana,” he replied, “there are some things about me you don’t know.” He told me about his three sons, all of whom enlisted after 9/11.
Two of his sons returned from the battlefield whole and healthy. The third, however, came home suffering multiple seizures each day. His prospects were bleak.
His medical care fell under the total guidance of the Department of Veterans Affairs, whose doctors came under federal restraints regarding the treatments they could prescribe. (Among the treatments allowed were opioids.) Nothing worked.
Finally, a sympathetic doctor advised our young hero to see him in his private office, where he could prescribe medication derived from cannabis. The prescription worked. The seizures, for the most part, ceased.
“Dana,” said my friend, “I could hug you right now for what you’ve been doing, unknowingly, for my son.”
What had I been doing? With my Democrat friend Sam Farr, the now-retired California congressman, I wrote an amendment to spending bills that prohibits the federal government from prosecuting medical marijuana cases in states where voters have legalized such treatment. The amendment passed two consecutive years, the second time with a wider margin than the first, and has been extended through continuing resolutions and an omnibus spending bill.
Unfortunately, my longtime friend Jeff Sessions, the attorney general, has urged Congress to drop the amendment, now co-sponsored by Rep. Earl Blumenauer (D-Ore.). This, despite President Trump’s belief, made clear in his campaign and as president, that states alone should decide medical marijuana policies.
I should not need to remind our chief law enforcement officer nor my fellow Republicans that our system of federalism, also known as states’ rights, was designed to resolve just such a fractious issue. Our party still bears a blemish for wielding the “states’ rights” cudgel against civil rights. If we bury state autonomy in order to deny patients an alternative to opioids, and ominously federalize our police, our hypocrisy will deserve the American people’s contempt.
You can read the whole article here.
The amendment must be approved by the House Rules Committee in order to get a vote, where it will likely be approved for the FY 2018 federal budget. If it is not, a conference committee will need to choose the Senate version of the budget later this month. If one of these two options doesn't happen, medical marijuana patients and providers will be open to federal prosecution once again.
budget, Congress, Dana Rohrabacher, Democrat, Earl Blumenauer, House Rules Committee, Jeff Sessions, Republican, Sam Farr, Veterans Affairs, Washington Post
Yet another study was released this week showing that teen marijuana use did not increase after legalization, this time from Washington.
Seattle Times reports:
Youth use of pot and cannabis-abuse treatment admissions have not increased in Washington since marijuana was legalized, according to a new analysis by the state Legislature’s think tank.
Under Initiative 502, the state’s legal-pot law, the Washington State Institute for Public Policy (WSIPP) is required to conduct periodic cost-benefit analyses of legalization on issues ranging from drugged-driving to prenatal use of marijuana.
...
The think tank’s findings on youth use were not surprising as they were based on a biannual survey by the state Department of Health of students in the sixth, eighth, 10th and 12th grades released earlier this year.
Pot use by students in all four grade levels was stable or has fallen slightly since I-502 was enacted, the WSIPP report said.
For instance, 17 percent of the 10,835 high-school sophomores surveyed last year said they consumed pot in the previous month. The level was 18 percent in 2006 and 20 percent in 2010.
Legalization was approved by Washington voters in November 2012. Legal sales began in July 2014.
The study also found that admissions to public treatment centers for cannabis abuse had fallen since legalization took effect, and that the cannabis industry had created more than six thousand full-time jobs.
Department of Health, I-502, Seattle Times, teen use, WA, Washington, Washington State Institute for Public Policy
House Speaker Beth Harwell and Lieutenant Governor Randy McNally formed a committee to study the potential impacts of legalizing medical marijuana in Tennessee.
The committee will be chaired by Sen. Steve Dickerson, R-Nashville, and Rep. Jeremy Faison, R-Cosby, who has been a staunch advocate for medical marijuana in the Volunteer State.
Speaker Harwell has recently said she is "open" to considering a law allowing medical marijuana in Tennessee and has launched a House task force to fight the state's ongoing opioid crisis.
A 2014 study published in the Journal of the American Medical Association found that states with medical marijuana laws are associated with a significant reduction in mortality from opioid abuse; these states saw a 25% reduction in opioid overdose deaths, compared to states without such laws.
Beth Harwell, Cosby, Jeremy Faison, Journal of the American Medical Association, Nashville, Randy McNally, Steve Dickerson, Tennessee
The Alaska Marijuana Control Board published proposed rules for cannabis cafés. Please take a look and consider submitting written comments in support.
It’s important for the board to hear that the public wants adults to be allowed to consume cannabis at regulated establishments.
Comments are due by October 27 at 4:30 p.m., and they may be submitted by email to amco.regs@alaska.gov, or by regular mail. For more information on making submissions, please see the state’s public notice, available online here. While comments are not due until late October, we strongly encourage you to submit them early so that board members have time to review and consider submissions.
Under the current proposal, the state would allow cannabis flowers to be purchased and consumed on-site by vaporization or smoking, one gram at a time. Concentrates would not be available. Cannabis edibles and food that does not contain cannabis could also be available. A newly proposed addition to the rules would ensure cannabis café workers are not exposed to marijuana smoke while on duty.
The status quo is unworkable for the state’s tourists, and adult residents should not be relegated to private homes when alcohol consumers can choose from a variety of bars and restaurants. It is also important to ensure renters — whose leases may prohibit cannabis consumption — are not shut out of the freedoms Alaskan homeowners enjoy.
Alaska, cannabis cafes, Marijuana Control Board, social consumption
In November 2016, Denver voters approved a measure that allows local businesses to apply for permits to set aside areas for marijuana consumption by their customers. Now, after months of conflict over the extremely restrictive nature of the rules, the city is accepting applications.
Advocates are still decrying the regulations, however, saying that the rules are designed to make it almost impossible for most businesses to take part. In particular, they are concerned that a requirement that applicants be at least 1,000 feet from a variety of educational, treatment, and public facilities, including city parks, eliminates most potential applicants and is unfair when compared to much less restrictive buffer zones for businesses that sell alcohol. Locals are considering a lawsuit against the city to address this issue.
The Virginia State Crime Commission has rescheduled its meeting to present its findings on marijuana decriminalization. It’s important that advocates attend this meeting and show that Virginians support sensible marijuana policies.
What: Virginia State Crime Commission public meeting to present its findings on marijuana decriminalization
When: Monday, October 30, at 1 p.m.
Where: House Committee Room, Ground Floor, Room W011, Pocahontas Building, 900 East Maine Street, Richmond, VA
Don’t forget that the Commission is still accepting written comment on marijuana decriminalization. The specific issues it’s examining are available here. Make sure to submit your comments by Friday, August 23, at 5 p.m. You can email them to vsccinfo@vscc.virginia.gov or mail them to:
1111 East Broad Street, Ste. B036
Richmond, VA 23219
Be sure to check out our decriminalization webpage for assistance crafting your comments. Here are some of the best key points to hit:
Please spread the word to other Virginians who support humane marijuana policies.
decriminalization, Richmond, Virginia, Virginia State Crime Commission
New Hampshire’s therapeutic cannabis law is finally expanding to include patients who suffer from chronic pain. HB 157 went into effect on Tuesday, adding “moderate to severe chronic pain” as a qualifying condition. This new law will allow many more Granite Staters to use cannabis as an alternative to prescribed opioids — a critically important reform for a state that is struggling to turn the tide against opiate addiction.
Until this week, patients could only qualify with a pain diagnosis if their pain was deemed to be “severe” and related to one of the specific medical conditions provided for in the law. As a result, it was much easier for medical providers to prescribe opioids than to certify patients for therapeutic cannabis. Patients who would like to apply now that the law has changed can access the updated application forms here.
For those who are waiting for the addition of post-traumatic stress disorder (PTSD), that is scheduled to take effect on August 27.
The Utah Patients Coalition held a news conference on Thursday to announce the official launch of signature gathering efforts to get a medical marijuana initiative on the Nov. 2018 ballot. Volunteers began collecting signatures in downtown Salt Lake City immediately following the event.
The Utah Medical Cannabis Act received approval from Lt. Governor Spencer Cox on August 10 to begin gathering signatures after supporters held 10 public hearings across the state and met with various state departments and stakeholders. More than 113,000 valid signatures are required to qualify for the ballot.
Good 4 Utah reports:
They are due April 15, 2018, but this group wants to get all the signatures turned in before the 2018 Legislative Session starts.
...
"The legislature has had an opportunity for the last three or four years to make substantive policy on this and has failed to do so, so now I think it's time for the people to decide on this issue," said DJ Schanz, Utah Patients Coalition Campaign Director.
The initiative would allow patients with certain qualifying conditions to legally and safely access medical cannabis with the recommendation of their doctor. It limits the number of dispensaries and cultivators, allows local zoning for medical cannabis facilities, prohibits using medical cannabis in public view, maintains the illegality of driving while intoxicated, and closely mirrors the legislation passed by the Utah Senate in 2016. Home cultivation and smoking medical cannabis would not be permitted.
DJ Schanz, Good 4 Utah, press conference, Salt Lake City, signature drive, Spencer Cox, Utah Medical Cannabis Act, Utah Patients Coalition
With nine months left to gather signatures, the hard-working volunteers of New Approach Missouri are well on their way with over 50,000 already collected! The total number required to qualify for the 2018 ballot is 160,199.
However, gathering enough total signatures is only one part of the process in Missouri. It is also necessary that the signatures be distributed across different congressional districts in the state. So New Approach Missouri is planning to hire a professional petitioning firm to help push the campaign over the finish line and to ensure that geographic distribution requirements are met.
In other news, the list of advocates calling for medical marijuana in Missouri has expanded to include retired NFL player Kyle Turley, who played for both the Kansas City Chiefs and the St. Louis Rams! Kyle is a patient and an advocate because medical marijuana has allowed him to live without pain and painkillers, as well as helping him to overcome depression. Check out his story here.
Kansas City Chiefs, Kyle Turley, Missouri, New Approach Missouri, petition, signature, St. Louis Rams